ALISKIREN

Clinical Indication

Existing patients with Hypertension

Comments

Full SCA

Date of classification

June 2022

Orange

Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.